Clinical Trial Update: Intravenous Versus Subcutaneous Administration of Low Molecular Weight Heparin for Thromboprophylaxis in Critically Ill Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing intravenous versus subcutaneous administration of low molecular weight heparin for thromboprophylaxis in critically ill patients has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: Clinique Saint Pierre Ottignies | Conditions: Critical Illness | Phase 4 | Status: COMPLETED